 |
|
TREATMENT OF RHUS DERMATITIS WITH TOPICAL HYDROCORTISONEA Clinical Evaluation
IRWIN B. ESKIND, M.D.;
COLONEL ROLLAND B. SIGAFOOS;
LIEUTENANT RAYMOND W. KELSO, Jr.
AMA Arch Derm Syphilol. 1954;69(4):410-413.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
THE FAILURE of older remedies—boric acid or permanganate soaks; topical antihistamines; calamine lotion; and superficial anesthetic agents—to prevent spread and to alleviate symptoms of Rhus dermatitis has led to the recent study of corticotropin (adrenocorticotropic hormone) and cortisone in this condition. At the present time a divided opinion exists as to the value of these agents in this disease. Such a variance in reported results can be appreciated by a consideration of the nature of Rhus dermatitis, especially the protean course of the disease in different individuals.
In the treatment of 15 patients with Rhus dermatitis by the use of 500 to 1000 mg. of oral cortisone over a four- to seven-day period, Wrong and Smith noted a good to excellent response in 73% of their cases. Falk reported a series of nine patients hospitalized because of Rhus dermatitis. These patients were treated for three days with either oral cortisone
. . . [Full Text PDF of this Article]
Author Affiliations
NASHVILLE, TENN.; MEDICAL CORPS, UNITED STATES ARMY
From the United States Army Hospital, United States Military Academy, West Point, N. Y.
Footnotes
For this study 0.2% hydrocortisone lotion was furnished by Smith, Kline & French Laboratories, Philadelphia; 1.0 and 2.5% hydrocortisone ointment by Merck & Company, Inc., Rahway, N. J., and 2.5% hydrocortisone cream by The Upjohn Company, Kalamazoo, Mich.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
